SCHEMBL7950657

SCHEMBL7950657

CCCOc1ccc(OC)cc1C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.51
MTNR1B P49286 2/20 0.51
MAPT P10636 4/20 0.49
MEN1 O00255 1/20 0.49
NR1I2 O75469 1/20 0.49
LMNA P02545 1/20 0.49
CHRM2 P08172 1/20 0.49
CYP3A4 P08684 1/20 0.49
ADRA2A P08913 1/20 0.49
OPRK1 P41145 1/20 0.49
HTR2B P41595 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 4/20 0.47
CLK1 P49759 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HTR1A P08908 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951260 0.89 PARP15 (0.51) MTNR1AMTNR1BMAPTMEN1NR1I2
SCHEMBL8981628 0.88 KDM4E (0.47) MTNR1AMTNR1BMAPTMEN1NR1I2
SCHEMBL11627742 0.88 MAPK1 (0.56) MTNR1AMTNR1BMAPTMEN1LMNA
Hydrochloric Acid SCHEMBL11710451 0.86 MAPK1 (0.55) MTNR1AMTNR1BMAPTMEN1LMNA
SCHEMBL7962020 0.85 PRSS1 (0.47) MTNR1AMTNR1BMAPTMEN1LMNA
SCHEMBL6677588 0.84 LMNA (0.59) MAPTMEN1NR1I2LMNACHRM2
SCHEMBL14610854 0.84 MCL1 (0.52) MTNR1AMTNR1BMAPTMEN1NR1I2
Hydrochloric Acid SCHEMBL11629258 0.84 PRSS1 (0.48) MTNR1AMTNR1BMAPTMEN1LMNA
SCHEMBL16952978 0.83 MTNR1A (0.51) MTNR1AMTNR1BMAPTMEN1LMNA
SCHEMBL1086016 0.82 MAPT (0.66) MAPTMEN1LMNAKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed
US-4082751-A ANTIALLERGENS BRISTOL-MYERS COMPANY (US) 1978-04-04 US disclosed
US-4031093-A ANTIALLERGENS BRISTOL-MYERS COMPANY (US) 1977-06-21 US disclosed